Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1867 of 5804
-
Remote group sessions may hold key to long-term smoking abstinence
Disease control OngoingThis observational study evaluates a structured smoking cessation program delivered via weekly group sessions. The primary objective is to assess participant-reported smoking abstinence following completion of the program and at 6-month follow-up. Secondary objectives include ev…
Sponsor: Quit Center LLC • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New tool aims to predict chronic pain in cancer patients
Knowledge-focused Recruiting nowSuccessive and repeated therapeutic interventions during cancer management - surgery, chemotherapy, radiotherapy - can all, to varying degrees, generate acute pain, central pain sensitization and chronic pain. Almost 58% of patients suffer from chronic pain, often of the neuropat…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New urine test could spot kidney danger in ICU patients early
Diagnosis OngoingThe purpose of this research is to collect blood and urine from adult patients admitted to an intensive care unit. This is to assess the performance of the ProNephro AKI (NGAL) assay (lab test) as an aid to identify patients at risk for acute kidney injury.
Sponsor: BioPorto Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New device aims to filter out dangerous inflammation during heart surgery
Disease control CompletedThis prospective single-centre randomized controlled trial aims at evaluating the safety and efficacy of hemoadsorption with HA-380® during cardio-pulmonary bypass in 40 patients undergoing complex cardiac surgery.
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Physiotherapy after liver transplant may boost long-term physical and mental function
Knowledge-focused CompletedLiver transplantation is the most effective treatment for end-stage liver disease. However, many recipients continue to experience problems such as reduced physical function, impaired balance, fatigue, and cognitive difficulties even after successful transplantation. Although phy…
Sponsor: Hasan Kalyoncu University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Blood test may predict amyloidosis treatment success in days
Knowledge-focused Recruiting nowLight chain amyloidosis (AL amyloidosis) is a rare plasma cell dyscrasia characterized by the deposition of insoluble amyloid fibrils in multiple organ systems. The treatment of amyloidosis primarily relies on anti-plasma cell therapy and supportive care. The application of anti-…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New imaging agent could sharpen cancer detection
Diagnosis Recruiting nowMalignant tumors pose a serious threat to human health, and early diagnosis and early treatment are crucial to improving the patient's prognosis. Nuclear medicine imaging technology injects radioisotope labeled molecules (such as monoclonal antibodies and peptides) into the body …
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Zambia's new stroke unit could save lives
Disease control CompletedThe goal of this clinical trial is to evaluate the impact of a locally adapted stroke unit on outcomes of adults with stroke in Zambia. The main question\[s\] to answer are: • Does provision of evidence-based stroke care improve after implementation of a stroke unit at the Univer…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 26, 2026 13:54 UTC
-
Yoga vs. depression: no meds, just mats
Symptom relief Recruiting nowThe goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zucker…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Robot arm takes on rectal cancer in tiny trial
Disease control CompletedThis is a phase 2a clinical trial based on the IDEAL framework to evaluate the safety, feasibility and clinical efficacy of single-port robotic transanal total mesorectal excision (SPr-taTME )surgery. For safety, intraoperative adverse events and 30-day morbidity. For efficacy, s…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC
-
Could a $10 ruler save newborns from brain damage?
Diagnosis CompletedNewborn jaundice, or accumulation of bilirubin molecules in blood, affects 60-80% of newborns and, in severe cases, places newborns at risk of brain damage and death. Universal screening of all newborn for jaundice ensures that at-risk newborns are identified and treated early. T…
Sponsor: George Washington University • Aim: Diagnosis
Last updated Jun 27, 2026 12:39 UTC
-
New imaging agent could predict CAR-T success in lymphoma patients
Knowledge-focused Recruiting nowThis is a phase I/Ib imaging study of granzyme B, 64-copper granzyme targeting restricted interaction peptide specific to family member B (64Cu-GRIP B) Positron Emission Tomography (PET) in patients with relapsed/refractory non-Hodgkin's lymphoma (NHL) receiving CD19-directed Chi…
Phase: PHASE1 • Sponsor: Michael Randall • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis study is an open-label, dose-escalation and expansion, Phase I clinical study to evaluate the safety, tolerability, PK characteristics and preliminary antitumor activity of WJ47156 monotherapy and in combination with toripalimab in patients with advanced malignant solid tumo…
Phase: PHASE1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a brazilian diet plus supplements tame inherited high cholesterol?
Disease control OngoingThe main objective of this randomized clinical trial is to evaluate the effects of the adapted Brazilian Cardioprotective Diet (DICA Br) supplemented or not with phytosterols and/or krill oil in patients with a probable or definitive diagnosis of familial hypercholesterolemia (FH…
Phase: NA • Sponsor: Hospital do Coracao • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Heart artery showdown: balloon or stent for big vessels?
Disease control Recruiting nowRandomized, controlled, open and multicenter study that analyzes the vasomotor function 8 months after use of the drug-eluting balloon (DCB) vs. drug-eluting stent (DES) in vessels ≥ 3.5 mm
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Custom-Made cancer vaccine shows promise in early trial
Disease control OngoingMVX-ONCO-2 is a patient-specific, cell-based, active immunotherapy where the participant's immune response to their own tumor cells is stimulated and/or increased. MVX-ONCO-2 is composed of a cell suspension of irradiated autologous tumor cells and two capsules loaded with alloge…
Phase: PHASE1 • Sponsor: University Hospital, Geneva • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Ultrasound vs. stethoscope: new trial aims to clear fluid from lungs faster
Symptom relief Recruiting nowThe goal of this clinical trial is to investigate whether a lung ultrasonography (LUS)-guided decongestion strategy in adults hospitalized for acute heart failure (AHF) can improve patient-centered outcomes. The main questions it aims to answer are: * Does this strategy shorten…
Phase: NA • Sponsor: Antonio Leidi • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Blood filter shows promise for severe psoriasis in early trial
Disease control CompletedPsoriasis is a chronic, inflammatory skin condition driven by the immune system, marked by red, scaly plaques that commonly affect the scalp and nails. About 30% of psoriasis patients may develop psoriatic arthritis, especially those with severe psoriasis or lesions on the nails …
Phase: NA • Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can radio waves zap dry eye away? new trial tests device for stubborn cases
Symptom relief Recruiting nowThe goal of this prospective, 24-week, double-masked, randomized, sham-controlled clinical trials to compare clinical efficacy and safety of RF and MGX with MGX alone in patients with meibomian gland dysfunction-related dry eye disease. The main question it aims to answer is whet…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Eye drops could lift droopy eyelids without surgery
Symptom relief Recruiting nowThis is a Phase III Study to evaluate the efficacy and safety of STN1013800 Ophthalmic Solution in Chinese Patients with Acquired Blepharoptosis. At present, there are no medicines for the treatment of acquired blepharoptosis in China. Therefore, to evaluate the efficacy and sa…
Phase: PHASE3 • Sponsor: Santen Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC